• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

    2/9/24 4:31:42 PM ET
    $ALGN
    Industrial Specialties
    Health Care
    Get the next $ALGN alert in real time by email
    SC 13G/A 1 d653237dsc13ga.htm SC 13G/A SC 13G/A

     

     

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    SCHEDULE 13G/A

    (Rule 13d-102)

    INFORMATION TO BE INCLUDED IN STATEMENTS

    FILED PURSUANT TO RULES 13d-1(b), (c), AND (d)

    AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2

    (Amendment No. 17)

     

     

    Align Technology, Inc.

    (Name of Issuer)

    Common Stock, $0.0001 par value per share

    (Title of Class of Securities)

    016255101

    (CUSIP Number)

    December 31, 2023

    (Date of Event Which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☒ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP NO. 016255101    13G/A    Page 2 of 14 Pages

     

     

     1   

     NAME OF REPORTING PERSONS

     

    Grant Gund, as trustee for the Gordon Gund – Grant Gund #2 Trust, the Grant Gund 1999 Trust, the Gordon Gund - Grant Gund GST Article III Trust, the Gordon Gund - Grant Gund GST Article III-A Trust, the Llura Blair Gund Gift Trust, the Grant Owen Gund Gift Trust, the Kelsey Laidlaw Gund Gift Trust and the 2011 Grant Gund Descendants’ Trust and as sole manager of OLK Investments LLC and OLK Brookfield LLC

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☒

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     United States of America

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5   

     SOLE VOTING POWER

     

     884,603

       6  

     SHARED VOTING POWER

     

     171,000

       7  

     SOLE DISPOSITIVE POWER

     

     884,603

       8  

     SHARED DISPOSITIVE POWER

     

     171,000

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     1,055,603

    10  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     1.4%

    12  

     TYPE OF REPORTING PERSON

     

     IN


    CUSIP NO. 016255101    13G/A    Page 3 of 14 Pages

     

     

     1   

     NAME OF REPORTING PERSONS

     

    G. Zachary Gund, as trustee for the Gordon Gund – G. Zachary Gund #2 Trust, the Z Coppermine Trust, the Gordon Gund—G. Zachary Gund GST Article III Trust, the Gordon Gund - G. Zachary Gund GST Article III-A Trust, the G. Zachary Gund Descendants’ Trust, the Georgia Swift Gund Gift Trust and the Grant Gund 2017 Remainder Trust and as sole manager of GCG Investments LLC

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☒

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     United States of America

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5   

     SOLE VOTING POWER

     

     1,284,279

       6  

     SHARED VOTING POWER

     

     3,000

       7  

     SOLE DISPOSITIVE POWER

     

     1,284,279

       8  

     SHARED DISPOSITIVE POWER

     

     3,000

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     1,287,279

    10  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     1.7%

    12  

     TYPE OF REPORTING PERSON

     

     IN


    CUSIP NO. 016255101    13G/A    Page 4 of 14 Pages

     

     

     1   

     NAME OF REPORTING PERSONS

     

    Gordon Gund, as the sole manager of Gund CLAT Investments, LLC

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☒

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     United States of America

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5   

     SOLE VOTING POWER

     

     850,647

       6  

     SHARED VOTING POWER

     

     0

       7  

     SOLE DISPOSITIVE POWER

     

     850,647

       8  

     SHARED DISPOSITIVE POWER

     

     0

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     850,647

    10  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     1.1%

    12  

     TYPE OF REPORTING PERSON

     

     IN


    CUSIP NO. 016255101    13G/A    Page 5 of 14 Pages

     

     

     1   

     NAME OF REPORTING PERSONS

     

    Alison I. Glover, as trustee for the Llura Blair Gund Gift Trust, the Grant Owen Gund Gift Trust, the Kelsey Laidlaw Gund Gift Trust and the Georgia Swift Gund Gift Trust

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☒

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     United States of America

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5   

     SOLE VOTING POWER

     

     0

       6  

     SHARED VOTING POWER

     

     174,000

       7  

     SOLE DISPOSITIVE POWER

     

     0

       8  

     SHARED DISPOSITIVE POWER

     

     174,000

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     174,000

    10  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     0.2%

    12  

     TYPE OF REPORTING PERSON

     

     IN


    CUSIP NO. 016255101    13G/A    Page 6 of 14 Pages

     

     

     1   

     NAME OF REPORTING PERSONS

     

    Dionis Trust

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☒

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Ohio

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5   

     SOLE VOTING POWER

     

     -0-

       6  

     SHARED VOTING POWER

     

     187,700

       7  

     SOLE DISPOSITIVE POWER

     

     -0-

       8  

     SHARED DISPOSITIVE POWER

     

     187,700

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     187,700

    10  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     0.2%

    12  

     TYPE OF REPORTING PERSON

     

     OO


    CUSIP NO. 016255101    13G/A    Page 7 of 14 Pages

     

     

     1   

     NAME OF REPORTING PERSONS

     

    Marital Trust for Gordon Gund

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☒

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     Ohio

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5   

     SOLE VOTING POWER

     

     -0-

       6  

     SHARED VOTING POWER

     

     574,550

       7  

     SOLE DISPOSITIVE POWER

     

     -0-

       8  

     SHARED DISPOSITIVE POWER

     

     574,550

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     574,550

    10  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     0.8%

    12  

     TYPE OF REPORTING PERSON

     

     IN


    CUSIP NO. 016255101    13G/A    Page 8 of 14 Pages

     

     

     1   

     NAME OF REPORTING PERSONS

     

    Gordon & Llura Gund Foundation

     2  

     CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

     (a) ☐  (b) ☒

     

     3  

     SEC USE ONLY

     

     4  

     CITIZENSHIP OR PLACE OF ORGANIZATION

     

     New Jersey

    NUMBER OF

    SHARES

    BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

       5   

     SOLE VOTING POWER

     

     -0-

       6  

     SHARED VOTING POWER

     

     424,465

       7  

     SOLE DISPOSITIVE POWER

     

     -0-

       8  

     SHARED DISPOSITIVE POWER

     

     424,465

     9   

     AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     

     424,465

    10  

     CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES

     

     ☐

    11  

     PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)

     

     0.6%

    12  

     TYPE OF REPORTING PERSON

     

     IN


    CUSIP NO. 016255101    13G/A    Page 9 of 14 Pages

     

    This Amendment No. 17 (“Amendment No. 17”) amends and supplements the Schedule 13G as originally filed by Llura L. Gund, Grant Gund, G. Zachary Gund, Gordon Gund, Richard T. Watson, Rebecca H. Dent, George Gund III and Gail Barrows on September 25, 2002, the Amendment No. 1 filed on November 25, 2002, the Amendment No. 2 filed on February 17, 2004, the Amendment No. 3 filed on February 14, 2005, the Amendment No. 4 filed on February 7, 2006, the Amendment No. 5 filed on February 14, 2007, the Amendment No. 6 filed on February 13, 2009, the Amendment No. 7 filed on February 13, 2013, the Amendment No. 8 filed on February 14, 2014, the Amendment No. 9 filed on February 9, 2016, the Amendment No. 10 filed on February 9, 2017, the Amendment No. 11 filed on February 8, 2018, the Amendment No. 12 filed on February 11, 2019, the Amendment No. 13 filed on February 7, 2020, the Amendment No. 14 filed on February 11, 2021, the Amendment No. 15 filed on February 7, 2022 and the Amendment No. 16 filed on February 1, 2023 (as so amended, the “Schedule 13G”). Capitalized terms used but not defined in this Amendment No. 17 have the respective meaning ascribed to them in the Schedule 13G.

    Item 2 (a) of the Schedule 13G, “Identity and Background,” is hereby amended by deleting the last paragraph thereof and inserting the following:

    The Reporting Persons, in the aggregate, beneficially own 4,380,244 shares of Common Stock or 5.7% of the outstanding Common Stock of the Issuer based on 76,589,114 shares outstanding as of October 27, 2023 as reported in the Quarterly Report on Form 10-Q of the Issuer for the period ended September 30, 2023. Neither the fact of this filing nor anything contained herein shall be deemed to be an admission by any of the Reporting Persons that a group exists within the meaning of the Exchange Act.

    Item 4 of the Schedule 13G, “Ownership” is hereby amended and restated in its entirety as follows:

    Pursuant to the Exchange Act and regulations thereunder, the Reporting Persons may be deemed as a group to have acquired beneficial ownership of 4,380,244 shares of Common Stock, which represents 5.7% of the outstanding Common Stock of the Issuer.

    Grant Gund may be deemed to have beneficial ownership in the aggregate of 1,055,603 shares of Common Stock, which constitutes 1.4% of the outstanding Common Stock of the Issuer. Of these shares, Grant Gund has sole power to vote and sole power to dispose of an aggregate of 884,603 shares of Common Stock by virtue of his position as the sole manager or trustee or investment trustee of certain entities listed below and may be deemed to have shared power to vote and shared power to dispose of 171,000 shares of Common Stock by virtue of his position as co-trustee of certain trusts as listed below:

     

    Gordon Gund – Grant Gund #2 Trust (Mr. Grant Gund serves as investment trustee)

         270,379  

    Grant Gund 1999 Trust (Mr. Grant Gund serves as sole trustee)

         90,320  

    OLK Investments LLC (Mr. Grant Gund serves as sole manager)

         80,516  

    OLK Brookfield LLC (Mr. Grant Gund serves as sole manager)

         8,532  

    Gordon Gund - Grant Gund GST Article III Trust (Mr. Grant Gund serves as investment trustee)

         280,349  

    Gordon Gund - Grant Gund GST Article III-A Trust (Mr. Grant Gund serves as investment trustee)

         107,000  

    2011 Grant Gund Descendants’ Trust (Mr. Grant Gund serves as investment trustee)

         47,507  


    CUSIP NO. 016255101    13G/A    Page 10 of 14 Pages

     

    Llura Blair Gund Gift Trust (Mr. Grant Gund serves as co-trustee with Alison I. Glover)

         50,165  

    Grant Owen Gund Gift Trust (Mr. Grant Gund serves as co-trustee with Alison I. Glover)

         50,165  

    Kelsey Laidlaw Gund Gift Trust (Mr. Grant Gund serves as co-trustee with Alison I. Glover)

         70,670  

    G. Zachary Gund may be deemed to have beneficial ownership in the aggregate of 1,287,279 shares of Common Stock, which constitutes 1.7% of the outstanding Common Stock of the Issuer. Of these shares, G. Zachary Gund has sole power to vote and sole power to dispose of 1,284,279 shares of Common Stock by virtue of his position as the sole manager or trustee or investment trustee of certain entities listed below and may be deemed to have shared power to vote and shared power to dispose of 3,000 shares by virtue of his position as co-trustee for certain trusts as indicated below:

     

    Gordon Gund – G. Zachary Gund #2 Trust (Mr. G. Zachary Gund serves as investment trustee)

         328,887  

    Z Coppermine Trust (Mr. G. Zachary Gund serves as sole trustee)

         121,069  

    GCG Investments LLC (Mr. G. Zachary Gund serves as sole manager)

         14,875  

    Gordon Gund – G. Zachary Gund GST Article III Trust (Mr. G. Zachary Gund serves as investment trustee)

         322,998  

    Grant Gund 2017 Remainder Trust (Mr. G. Zachary Gund serves as trustee)

         11,450  

    Gordon Gund – G. Zachary Gund GST Article III-A Trust (Mr. G. Zachary Gund serves as investment trustee)

         107,000  

    G. Zachary Gund Descendants’ Trust (Mr. G. Zachary Gund serves as investment trustee)

         378,000  

    Georgia Swift Gund Gift Trust (Mr. G. Zachary Gund serves as co-trustee with Alison I. Glover)

         3,000  

    Gordon Gund may be deemed to have beneficial ownership of 850,647 shares of Common Stock, which constitutes 1.1% of the outstanding Common Stock of the Issuer. Gordon Gund, as sole manager of Gund CLAT Investments, LLC has sole power to vote and sole power to dispose of 850,647 shares of Common Stock.

    Alison I. Glover may be deemed to have beneficial ownership in the aggregate of 174,000 shares of Common Stock, which constitutes 0.2% of the outstanding Common Stock of the Issuer. Of these shares, Alison I. Glover may be deemed to have shared power to vote and shared power to dispose of an aggregate of 174,000 shares of Common Stock by virtue of her position as co-trustee for certain trusts as indicated below:

     

    Llura Blair Gund Gift Trust (Ms. Glover serves as co-trustee with Grant Gund)

         50,165  

    Grant Owen Gund Gift Trust (Ms. Glover serves as co-trustee with Grant Gund)

         50,165  

    Kelsey Laidlaw Gund Gift Trust (Ms. Glover serves as co-trustee with Grant Gund)

         70,670  

    Georgia Swift Gund Gift Trust (Ms. Glover serves as co-trustee with G. Zachary Gund)

         3,000  

    The Dionis Trust may be deemed to have beneficial ownership of 187,700 shares of Common Stock, which constitutes 0.2% of the outstanding Common Stock of the Issuer. The Dionis Trust has shared power to vote and shared power to dispose of 187,700 shares of Common Stock.


    CUSIP NO. 016255101    13G/A    Page 11 of 14 Pages

     

    The Marital Trust for Gordon Gund may be deemed to have beneficial ownership of 574,550 shares of Common Stock, which constitutes 0.8% of the outstanding Common Stock of the Issuer. The Marital Trust for Gordon Grund has shared power to vote and shared power to dispose of 574,550 shares of Common Stock.

    The Gordon & Llura Gund Foundation may be deemed to have beneficial ownership of 424,465 shares of Common Stock, which constitutes 0.6% of the outstanding Common Stock of the Issuer. The Gordon & Llura Gund Foundation has shared power to vote and shared power to dispose of 424,465 shares of Common Stock.

    Item 10. Certifications. (See Instructions)

    By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.


    CUSIP NO. 016255101    13G/A    Page 12 of 14 Pages

     

    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Dated: February 9, 2024

     

    By:   /s/ Catherine Bird
      Name: Catherine Bird
      For herself and as Attorney-in-Fact for the
      Reporting Persons

     

    *

    The Power of Attorney authorizing Catherine Bird to act on behalf of the Reporting Persons is attached hereto as Exhibit A.

    Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001).

    Get the next $ALGN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALGN

    DatePrice TargetRatingAnalyst
    7/9/2026$209.00Outperform
    BMO Capital Markets
    4/15/2026$240.00Buy
    Citigroup
    3/17/2026$200.00Equal Weight → Overweight
    Barclays
    2/9/2026$200.00Hold → Buy
    HSBC Securities
    12/9/2025$170.00Equal Weight
    Barclays
    10/10/2025$140.00Buy → Hold
    Jefferies
    7/31/2025$154.00Overweight → Equal-Weight
    Morgan Stanley
    4/25/2025$170.00Buy → Hold
    HSBC Securities
    More analyst ratings

    $ALGN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CHIEF LEGAL & REGULATORY Coletti Julie Ann bought $4,606 worth of shares (42 units at $109.66), increasing direct ownership by 0.59% to 7,110 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    8/1/25 5:58:45 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    PRESIDENT AND CEO Hogan Joseph M bought $996,131 worth of shares (7,576 units at $131.49), increasing direct ownership by 4% to 184,945 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    8/1/25 4:05:18 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Director Larkin C Raymond Jr bought $1,529,645 worth of shares (6,500 units at $235.33) and gifted 4,650 shares, increasing direct ownership by 9% to 23,597 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    8/19/24 6:35:02 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    SEC Filings

    View All

    Align Technology Inc. filed SEC Form 8-K: Leadership Update

    8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)

    7/8/26 8:29:04 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - ALIGN TECHNOLOGY INC (0001097149) (Filer)

    6/18/26 9:02:10 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    SEC Form SD filed by Align Technology Inc.

    SD - ALIGN TECHNOLOGY INC (0001097149) (Filer)

    5/29/26 4:13:54 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Operation Smile Announces Align Technology as Title Sponsor of 34th International Student Leadership Conference for Sixth Year

    Over six years, Align has contributed more than $2M to Operation Smile's student programs to send the next generation of global health advocates to the world stageVIRGINIA BEACH, Va., and TEMPE, Ariz., July 14, 2026 /PRNewswire/ -- Operation Smile, a global nonprofit deeply committed to closing the gap in surgical and health care access, today announced Align Technology, Inc. (NASDAQ:ALGN) as the title sponsor of its 2026 International Student Leadership Conference (ISLC), marking the sixth consecutive year of this sponsorship. Through nearly $3.8 million in total contributions benefiting Operation Smile's students and surgical programs, Align Technology is a key global partner, supporting y

    7/14/26 9:00:00 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology to Announce Second Quarter 2026 Results on July 29, 2026

    Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report second quarter 2026 financial results on Wednesday, July 29, 2026, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com.Following the press release, Align will host a conference call to discuss its financial results. The conference call will begin a

    7/1/26 8:30:00 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Statement on European Commission Proceeding

    Align Technology, Inc. ("Align") (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today responded to the European Commission’s June 30 press release announcing an investigation involving the Company based on a complaint made by an Align competitor. Align Technology is committed to conducting business with integrity and in full compliance with global competition laws. We believe fair, lawful competition drives innovation, expands choice, and delivers better outcomes for doctors and patients. Our suc

    6/30/26 8:21:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    BMO Capital Markets initiated coverage on Align Tech with a new price target

    BMO Capital Markets initiated coverage of Align Tech with a rating of Outperform and set a new price target of $209.00

    7/9/26 9:26:08 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    Citigroup initiated coverage on Align Tech with a new price target

    Citigroup initiated coverage of Align Tech with a rating of Buy and set a new price target of $240.00

    4/15/26 8:07:32 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Tech upgraded by Barclays with a new price target

    Barclays upgraded Align Tech from Equal Weight to Overweight and set a new price target of $200.00

    3/17/26 7:53:01 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Vitalone Britt J. converted options into 1,443 shares (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    5/22/26 7:18:21 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Director Siegel Susan E converted options into 1,745 shares, increasing direct ownership by 19% to 10,723 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    5/22/26 7:16:21 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Director Saia Andrea Lynn converted options into 1,745 shares, increasing direct ownership by 11% to 17,318 units (SEC Form 4)

    4 - ALIGN TECHNOLOGY INC (0001097149) (Issuer)

    5/22/26 7:15:13 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Financials

    Live finance-specific insights

    View All

    Align Technology to Announce Second Quarter 2026 Results on July 29, 2026

    Align Technology, Inc. (NASDAQ:ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report second quarter 2026 financial results on Wednesday, July 29, 2026, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com.Following the press release, Align will host a conference call to discuss its financial results. The conference call will begin a

    7/1/26 8:30:00 AM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Announces First Quarter 2026 Financial Results, $200M Stock Repurchase, and Reaffirms Fiscal 2026 Guidance

    Record Q1'26 Invisalign® Clear Aligner shipments of 685.7 thousand increased 6.7% year-over-year reflecting double-digit growth in the EMEA, APAC, and LATAM regions, and stability in North America Q1'26 Clear Aligner shipments to Orthodontists and GP Dentists increased 7.4% and 5.6% year-over-year, respectively Q1'26 Invisalign teen/kid patients increased 4.8% year-over-year and Invisalign adult patients increased 7.8% year-over-year Q1'26 total revenues were $1,040.1 million, down 0.7% sequentially and up 6.2% year-over-year Q1'26 total revenues were favorably impacted by foreign exchange by approximately $8.7 million sequentially, and favorably impacted by approximately $44.9 mi

    4/29/26 4:05:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology to Announce First Quarter 2026 Results on April 29, 2026

    Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report first quarter 2026 financial results on Wednesday, April 29, 2026, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will be

    4/1/26 4:23:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Leadership Updates

    Live Leadership Updates

    View All

    Align Technology Announces Board Leadership Transition. C. Raymond Larkin, Jr. to Retire as Chairman and Kevin Conroy to be Appointed Chairman Effective July 1, 2026

    Align Technology, Inc. ("Align") (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that C. Raymond Larkin, Jr. will retire as Chairman of the Board effective July 1, 2026, following more than 20 years of distinguished service on Align's Board of Directors. Mr. Larkin will continue to serve on the Board and as a member of the Nominating and Governance Committee through December 31, 2026, to support a smooth transition. Kevin Conroy will succeed Mr. Larkin as Chairman of the Board, eff

    6/18/26 9:01:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology's Invisalign® Brand Announces Official Sponsorship of Bay FC

    Sponsorship of National Women's Soccer League (NWSL) team highlights inspirational smile stories of women in sports and will help expand access to youth sports across the Bay Area Bay FC, the professional soccer franchise representing the San Francisco Bay Area in the National Women's Soccer League (NWSL), and Align Technology, a leading global medical device company that designs, manufactures, and sells the Invisalign® System of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced that Align Technology's Invisalign brand is an Official Partner of Bay FC. Through the sponsorship, Bay FC players who are

    3/25/25 4:00:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    Align Technology Appoints Emory Wright, EVP Direct Fabrication Manufacturing Platform to Build the Company's Next Generation Manufacturing Operations -- Wright Plans to Retire in 2026

    Align Technology, Inc. (NASDAQ:ALGN), a leading global medical device company that designs, manufactures, and sells the Invisalign® system of clear aligners, iTero™ intraoral scanners, and exocad™ CAD/CAM software for digital orthodontics and restorative dentistry, today announced it has appointed Emory Wright, executive vice president, direct fabrication manufacturing platform, effective immediately. Mr. Wright will transition his current responsibilities for global operations, including treatment planning, and focus on scaling Align's next generation direct fabrication manufacturing platform, working in close collaboration with Srini Kaza, who was promoted to executive vice president, res

    5/22/24 5:00:00 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    $ALGN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

    SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

    2/13/24 4:59:02 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

    SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

    2/9/24 4:31:42 PM ET
    $ALGN
    Industrial Specialties
    Health Care

    SEC Form SC 13G/A filed by Align Technology Inc. (Amendment)

    SC 13G/A - ALIGN TECHNOLOGY INC (0001097149) (Subject)

    2/9/23 11:07:31 AM ET
    $ALGN
    Industrial Specialties
    Health Care